Welcia (3141.T JPX) closes JPY 3,160 on 16 Mar 2026: Oversold bounce signal

3141.T stock closed at JPY 3,160.00 on 16 Mar 2026, down -2.86% but trading on heavy volume as a short-term oversold bounce formed. The move followed a wide intraday range from JPY 3,000.00 to JPY 3,345.00, with volume at 7,780,300 shares versus an average of 648,065. We view today’s action as a high-conviction short-term support test for Welcia Holdings (3141.T) on the JPX in Japan.

Market close and price action

Welcia Holdings (3141.T) ended the session at JPY 3,160.00, a -93.00 drop from the previous close of JPY 3,253.00. Trading ranged between JPY 3,000.00 and JPY 3,345.00, with 7,780,300 shares changing hands, about 12.01x average volume.

The wide range and high relative volume point to selling exhaustion followed by a bounce. Day and year highs show immediate resistance near JPY 3,345.00 while the 50-day average sits at JPY 2,929.49 and the 200-day average at JPY 2,579.99.

Why the oversold bounce matters for 3141.T stock

An oversold bounce often marks short-term support for retail and healthcare names. For 3141.T stock, the intraday recovery from JPY 3,000.00 suggests buyers defended that level, creating a tactical entry zone.

Given the stock’s YTD gain of 56.09% and recent pullback, short-term traders can treat the bounce as a gap-fill and mean-reversion setup while monitoring volume and price closing above JPY 3,200.00 for confirmation.

Fundamentals and valuation snapshot

Welcia’s trailing EPS is 92.27 with a trailing PE of 34.25 and market cap near JPY 655,965,433,680.00. Price-to-sales is 0.49 and price-to-book is 2.51, reflecting a premium linked to defensive retail pharmacy exposure.

Cash flow metrics show negative operating and free cash flow per share (operating -113.42, free -140.55), and dividend per share is 36.00 (yield about 1.14%). These mix growth with cash conversion pressure, a key risk to watch in any oversold bounce trade.

Meyka AI rates 3141.T with a score out of 100

Meyka AI rates 3141.T with a score out of 100: 74.11 / B+ (BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Technicals show the 50-day average (JPY 2,929.49) above the 200-day average (JPY 2,579.99), supporting a medium-term uptrend. High intraday volume and a large relative volume reading (12.01) make this a candidate for a tactical oversold bounce play, not a long-term signal by itself.

Analyst view, price targets and risks for 3141.T stock

There is no formal price-target consensus available; we use near-term technicals to set targets. Key levels: support JPY 3,000.00, immediate resistance JPY 3,345.00, and conservative upside target JPY 3,600.00 for a bounce trade. A protective stop near JPY 2,900.00 limits downside.

Risks include weaker free cash flow, margin pressure (operating margin 3.03%) and broader sector underperformance. A sustained close below JPY 2,900.00 would invalidate the oversold bounce thesis.

Trading strategy and tactical plan

For the oversold bounce strategy on 3141.T stock, consider a small initial position sized to risk tolerance. Use a stop at JPY 2,900.00 and scale out at JPY 3,345.00 and JPY 3,600.00. Target horizon: 1–4 weeks unless new fundamental news arrives.

Monitor volume: a follow-through day with above-average volume and a close above JPY 3,200.00 improves the odds. Use position sizing so a stop loss sized to ~5-8% of portfolio risk matches your limits.

Final Thoughts

Key takeaways: 3141.T stock closed JPY 3,160.00 on 16 Mar 2026 after an oversold bounce on heavy volume that points to short-term support around JPY 3,000.00 and resistance at JPY 3,345.00. Meyka AI’s forecast model projects a one-year model value of JPY 1,709.43, implying -45.94% versus today’s price; forecasts are model-based projections and not guarantees. Use the oversold bounce as a tactical trade with tight risk controls: stop near JPY 2,900.00 and partial profit-taking at JPY 3,345.00 and JPY 3,600.00. Remember sector context: healthcare in Japan is defensive but faces margin pressure, so treat this as a short-term setup. Meyka AI provides this analysis as an AI-powered market analysis platform; conduct your own due diligence before trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.